---
schema_version: "secwatch.filing_event.v1"
accession: "0002023658-25-000082"
form_type: "8-K"
ticker: "BCAX"
cik: "0002023658"
company_name: "Bicara Therapeutics Inc."
filed_at: "2025-06-12T23:59:59+00:00"
generated_at: "2026-05-19T11:37:08.446830+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.15
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Bicara Therapeutics shareholders elect three Class I directors, ratify KPMG

## Summary
- Elected Kiran Mazumdar-Shaw, Jake Simson, and Ryan Cohlhepp as Class I directors for three-year terms.
- Vote results: Mazumdar-Shaw 30.8M for, 14.4M withheld; Simson 37.6M for, 7.6M withheld; Cohlhepp 44.8M for, 0.4M withheld.
- Broker non-votes of approximately 2.6M shares on each director election.
- Ratification of KPMG as auditor for FY2025 passed with 47.7M for, 7.8K against, 3.3K abstain.

## SEC filing metadata
- accession: 0002023658-25-000082
- form_type: 8-K
- ticker: BCAX
- cik: 0002023658
- company_name: Bicara Therapeutics Inc.
- filed_at: 2025-06-12T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.15
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/2023658/000202365825000082/0002023658-25-000082-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/2023658/000202365825000082/bcax-20250609.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0002023658-25-000082
- JSON: https://secwatch.observer/filing/0002023658-25-000082.json
- Plain text: https://secwatch.observer/filing/0002023658-25-000082.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.